Company Data
Sutro Biopharma Inc.
Ticker
STRO
Current Price
$10.99 -4.1%
Market Cap
$182.2M
Price Target
Refer to Report
Volume
205.9K
52wk Range
$7.15 - $43.85
Overview
Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.